CLINICAL ROLE -
CDC: Cryptosporidium Outbreaks Linked to Swimming Have Doubled
Outbreaks of a parasitic infection linked to swimming pools and water playgrounds are increasingly being reported to CDC, with twice as many outbreaks in 2016 as in 2014.
Read More
Lower Cost Topical Steroids Could Save Millions
Low-cost generic topical steroids could save Medicare $944.8 million.
Impact of Patient Satisfaction on Specialty Pharmacy
Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.
How Are Other Countries Doing in the Continuum of HIV Care?
Non-EU and EEA countries trail behind in reaching viral suppression target by 2020.
Opioid Use Similar Between Veterans, General Public
Opioid use among Afghanistan, Iraq veterans similar to general population.
Trending News Today: 3-D Technology May Restore Fertility Lost to Chemotherapy
Top news of the day from across the health care landscape.
Obesity Increases Childhood Diabetes Risk
Children with obesity may be 4 times more likely to develop type 2 diabetes.
Trending News Today: Guidelines Recommend No Fruit Juice for Kids Under 1
Top news of the day from across the healthcare landscape.
MS Drug Class May Increase Adverse Events
Side effects associated with interferon beta for multiple sclerosis highlight the need for additional post-market surveillance for approved drugs.
Immunotherapy May Treat Multiple Cancer Types
Nanoparticle vaccines can travel directly to the lymph nodes to activate tumor-specific immune responses.
Cancer Drug Shows Promise Treating Asthma
Imatinib found to reduce measures of airway inflammation in severe asthma.
Gleevec Reduces Airway Inflammation in Severe Asthma
Cancer drug shows promise improving asthma symptoms.
Bring Your Own Weather: How Your Attitude Affects Others
How much do your actions affect those around you? Read here to learn about how to consciously change your environment.
New Cancer Drug Approvals Highlight AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
T Cell Therapy Trial Death in Top Cancer News of the Week
Top news of the week in oncology and cancer drug development.
Cognitive Issues Associated with Immune Responses to HIV, Flu
In a study published in Nature Medicine, investigators found that when a virus enters the bloodstream it activates the first responder immune cells, CX3CR1highLY6Clow monocytes.
Real-World Data Reveals Potential Adverse Events for Multiple Sclerosis Drug
Interferon beta may increase the risk of stroke, migraine, and depression among patients with multiple sclerosis.
Immune Response to HIV, Influenza May Cause Cognitive Issues
Virus-driven immune activation blocks connections between nerve cells in the brain.
Is Artificial Intelligence the Future of Cervical Cancer Detection?
A novel AI image detection method could potentially outperform current PAP and HPV tests.
Drug Therapy Superior to Implant for Uveitis Treatment
Systemic therapy observed to be more effective at preserving vision than intraocular implants in uveitis.
Trending News Today: Motion Filed to Maintain ACA Subsidies
Maternal High-Fat Diet Linked to Liver Disease in Mice
Mice born to mothers who ate a high-fat diet developed liver fibrosis.
Need for Improved Data Infrastructure Highlights SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
Trending News Today: Advanced Breast Cancer Survival Rates Improving
Updated Hepatitis C Guidelines Seek to Accelerate Testing Rates
The Guide to Hepatitis C Testing addresses widespread uncertainty regarding HCV treatment.
Updated Hepatitis C Testing Guidelines Improve Patient Education
The Guide to Hepatitis C Testing summarizes the latest examination recommendations.
Pharmacy Week in Review: May 19, 2017
A look at the top stories in pharmacy last week.
Watch
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Could This Cancer Drug Benefit Patients with Severe Asthma?
An early-phase study suggests that a targeted cancer drug, imatinib (Gleevec, Novartis), may help treat patients with severe asthma.
Chronic Care Management (CCM): The New Player
Chronic Care Management is a program that is now covered through Medicare part B.
